With over 25 years of experience, BioSpring is a privately owned company headquartered in Frankfurt, Germany, with a global presence. Their team of 400 employees is dedicated to advancing the potential of oligonucleotides through innovation. They produce APIs based on oligonucleotides, aiming to bring hope to patients with incurable diseases.